OncoSil Medical Limited (ASX:OSL)
Australia flag Australia · Delayed Price · Currency is AUD
0.0040
0.00 (0.00%)
Apr 4, 2025, 3:36 PM AEST

OncoSil Medical Revenue

OncoSil Medical had revenue of 985.38K AUD in the half year ending December 31, 2024, with 21.71% growth. This brings the company's revenue in the last twelve months to 1.91M, up 47.09% year-over-year. In the fiscal year ending June 30, 2024, OncoSil Medical had annual revenue of 1.57M with 6.68% growth.

Revenue (ttm)
1.91M
Revenue Growth
+47.09%
P/S Ratio
6.75
Revenue / Employee
n/a
Employees
n/a
Market Cap
18.43M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 20241.57M97.96K6.68%
Jun 30, 20231.47M404.03K38.00%
Jun 30, 20221.06M-234.94K-18.10%
Jun 30, 20211.30M-1.47M-53.02%
Jun 30, 20202.76M-862.28K-23.78%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CSL Limited 24.61B
Pro Medicus 184.58M
Cochlear 2.31B
Sonic Healthcare 9.33B
Telix Pharmaceuticals 783.21M
Ramsay Health Care 17.12B
Ansell 3.00B
Mesoblast 9.16M
Revenue Rankings